ViaNautis Bio Monday announced partnership with Eli Lilly and Company (LLY) to use ViaNautis' proprietary drug delivery platform polyNaut in delivering genetic medicines.
ViaNautis' polyNaut, a nanovesicles platform, is designed to direct therapeutics to specific targets with precision.
As per the agreement, ViaNautis will receive an initial upfront payment from Lilly with additional milestone payments.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.